PENTAVAC sub sèche+susp+aiguilles ser pré
7680006130012
CH-613
J07CA06
08.08.
1 / 2
google
Details
- Product number
- 0061301
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- I) composant DPTa-IPV (suspension): toxoidum diphtheriae min. 20 U.I., toxoidum tetani min. 40 U.I., bordetellae pertussis antigenum: toxoidum pertussis 25 µg et haemagglutininum filamentosum 25 µg, virus poliomyelitis typus 1 inactivatus 29 U., virus poliomyelitis typus 2 inactivatus 7 U., virus poliomyelitis typus 3 inactivatus 26 U., aluminium 0.3 mg ut aluminii hydroxidum hydricum ad adsorptionem, formaldehydum, medium 199 cum phenylalaninum 12.5 µg et kalium, acidum aceticum glaciale q.s. ad pH, natrii hydroxidum q.s. ad pH, phenoxyethanolum, ethanolum anhydricum 2 mg, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml, residui: neomycinum, streptomycinum, polymyxinum B nihil. II) composant Hib (poudre): polysaccharida haemophili influenzae typus B 1482 conjugata cum toxoido tetani 10 µg, trometamolum, saccharum, acidum hydrochloridum q.s. ad pH, pro praeparatione.
Articles (1)
Pentavac, Poudre et suspension pour suspension injectable
Puder
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
I
|
- | Substance | Wirkstoff (Principe actif) |
|
II
|
10.0 UG | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | HNIDK |
|
I
|
- | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | HNIDK |
|
I
|
- | Substance | Wirkstoff (Principe actif) |
|
I
|
25.0 UG | Substance | WIIS |
|
II
|
- | Substance | HNIDK |
|
I
|
25.0 UG | Substance | WIIS |
|
I
|
29.0 U | Substance | Wirkstoff (Principe actif) |
|
I
|
7.0 U | Substance | Wirkstoff (Principe actif) |
|
I
|
26.0 U | Substance | Wirkstoff (Principe actif) |
|
I
|
0.3 MG | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
I
|
12.5 UG | Substance | HBESI |
|
I
|
- | Substance | HBESI |
|
I
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
I
|
- | Substance | Konservierungsstoff (Conservateur) |
|
I
|
2.0 MG | Substance | HBESI |
|
I
|
- | Substance | HNIDK |
|
I
|
- | Substance | HIMDK |
|
I
|
- | Substance | HIMDK |
|
I
|
- | Substance | Wirkstoff (Principe actif) |
Reimbursement information
Public price
CHF 53.60
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/04/2000
Authorization holder
Sanofi-Aventis (Suisse) SA
1214 Vernier
Authorization information
- Swissmedic authorization number
- 613
- Drug name
- Pentavac, Poudre et suspension pour suspension injectable
- Galenic form
- PULSIN
- ATC Code
- J07CA06
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 18/08/1999
- Authorization expiration date
- 31/12/9999
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- PENTAVAC sub sèche+susp+aiguilles ser pré
- Description (DE)
- PENTAVAC Trockensub+Susp+Nadeln Fertspr
- Market launch
- 18/08/1999
- Narcotic (BTM)
- No
Application methods
IMU